Researching Rheumatoid Arthritis

Rheumatoid arthritis (RA) is an autoimmune disorder characterized by joint swelling, pain, and damage from chronic inflammation. RA occurs in roughly 5 per 1,000 people and may cause severe and irreversible joint damage and debilitation1. The key to combating RA is early diagnosis and treatment with various anti-inflammatory agents collectively known as disease-modifying antirheumatic drugs (DMARDs), which can prevent or slow joint damage in 90% of patients. Unfortunately, no cure for the disease exists, meaning that lengthy and potentially costly treatment regimens are often necessary. As such, RA research is very important for identifying more effective therapeutic agents.

Read the entire Case Study